Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Related Sciences has not published direct clinical results under its own name but has launched multiple risk-mitigated biotech ventures such as Danger Bio. These ventures are designed using RS’s proprietary data science platform to maximize the probability of success by focusing on validated human biology and multi-modality approaches. For example, Danger Bio launched with 15 preclinical programs targeting root drivers of autoimmunity and cancer microenvironments
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Related Sciences.